Return on Assets (ROA)
since 2005
Calculation
Edwards Lifesciences Corp., ROA, long-term trends, calculation
| ROA | = | 100 | × | Net income1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | 17.68% | = | 100 | × | 1,503,100) | ÷ | 8,502,600) |
| Dec 31, 2020 | 11.38% | = | 100 | × | 823,400) | ÷ | 7,237,100) |
| Dec 31, 2019 | 16.14% | = | 100 | × | 1,046,900) | ÷ | 6,488,100) |
| Dec 31, 2018 | 13.57% | = | 100 | × | 722,200) | ÷ | 5,323,700) |
| Dec 31, 2017 | 10.25% | = | 100 | × | 583,600) | ÷ | 5,695,800) |
| Dec 31, 2016 | 12.63% | = | 100 | × | 569,500) | ÷ | 4,510,000) |
| Dec 31, 2015 | 12.19% | = | 100 | × | 494,900) | ÷ | 4,059,300) |
| Dec 31, 2014 | 23.01% | = | 100 | × | 811,100) | ÷ | 3,524,300) |
| Dec 31, 2013 | 14.38% | = | 100 | × | 391,700) | ÷ | 2,724,700) |
| Dec 31, 2012 | 13.20% | = | 100 | × | 293,200) | ÷ | 2,221,500) |
| Dec 31, 2011 | 11.95% | = | 100 | × | 236,700) | ÷ | 1,980,500) |
| Dec 31, 2010 | 12.34% | = | 100 | × | 218,000) | ÷ | 1,767,200) |
| Dec 31, 2009 | 14.18% | = | 100 | × | 229,100) | ÷ | 1,615,500) |
| Dec 31, 2008 | 9.21% | = | 100 | × | 128,900) | ÷ | 1,400,200) |
| Dec 31, 2007 | 8.40% | = | 100 | × | 113,000) | ÷ | 1,345,100) |
| Dec 31, 2006 | 10.47% | = | 100 | × | 130,500) | ÷ | 1,246,800) |
| Dec 31, 2005 | 6.45% | = | 100 | × | 79,300) | ÷ | 1,229,100) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The financial performance between 2005 and 2021 is characterized by a substantial expansion in both net income and total assets, reflecting a long-term growth trajectory. While net income grew from 79.3 million USD to 1.5 billion USD, total assets increased from 1.2 billion USD to 8.5 billion USD, indicating that earnings growth significantly outpaced the accumulation of assets over the 16-year period.
- Net Income Trajectory
- Net income exhibited a consistent upward trend, with a notable acceleration beginning in 2013. A significant surge occurred in 2014, where income more than doubled from the previous year's 391.7 million USD to 811.1 million USD. Following a contraction in 2015, earnings recovered and peaked in 2021 at 1.5 billion USD.
- Asset Base Expansion
- Total assets demonstrated steady and nearly linear growth, expanding from 1.2 billion USD in 2005 to 8.5 billion USD in 2021. This consistent increase in the balance sheet size suggests ongoing investment in the company's infrastructure and operational capacity to support its growth.
- Return on Assets (ROA) Efficiency
- The ROA fluctuated over the observed period, starting at 6.45% in 2005 and ending at 17.68% in 2021. A primary peak in asset efficiency was recorded in 2014 at 23.01%, which coincides with the sharp spike in net income. This was followed by a correction to 12.19% in 2015. Despite this volatility, the ROA generally maintained a level above 10% from 2006 onward, signifying a sustained improvement in the ability to generate profit from the asset base compared to the baseline in 2005.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
Edwards Lifesciences Corp., ROA, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | 17.68% | 9.40% | 6.26% | 12.58% | 3.87% | 8.15% |
| Dec 31, 2020 | 11.38% | 6.20% | 5.28% | 9.50% | 5.28% | 7.81% |
| Dec 31, 2019 | 16.14% | 5.43% | 6.21% | 14.17% | 5.16% | 7.96% |
| Dec 31, 2018 | 13.57% | 3.53% | 5.24% | 14.37% | 3.40% | 7.87% |
| Dec 31, 2017 | 10.25% | 0.63% | 5.45% | 11.46% | 4.04% | 7.59% |
| Dec 31, 2016 | 12.63% | 2.66% | 3.79% | 11.34% | 3.55% | 5.71% |
| Dec 31, 2015 | 12.19% | 10.72% | 4.15% | 12.00% | 2.51% | 5.22% |
| Dec 31, 2014 | 23.01% | 5.53% | 4.14% | 10.58% | 8.08% | 6.50% |
| Dec 31, 2013 | 14.38% | 6.00% | 4.18% | 16.99% | 9.95% | 6.87% |
| Dec 31, 2012 | 13.20% | 8.87% | 4.50% | 16.18% | 10.93% | 6.83% |
| Dec 31, 2011 | 11.95% | 7.84% | 5.09% | 16.16% | 10.18% | 7.57% |
| Dec 31, 2010 | 12.34% | 7.78% | 5.75% | 15.97% | 11.03% | 7.35% |
| Dec 31, 2009 | 14.18% | 10.96% | 9.10% | 12.85% | 9.17% | 6.47% |
| Dec 31, 2008 | 9.21% | 11.51% | 5.15% | 13.86% | 10.05% | 5.33% |
| Dec 31, 2007 | 8.40% | 9.08% | 6.43% | 13.90% | 14.36% | 9.14% |
| Dec 31, 2006 | 10.47% | 4.75% | 5.98% | 10.72% | 12.95% | 8.61% |
| Dec 31, 2005 | 6.45% | 11.57% | 4.79% | 18.77% | 10.86% | 7.98% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Edwards Lifesciences Corp., ROA, long-term trends, comparison to sector (health care equipment & services)
| Edwards Lifesciences Corp. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2021 | 17.68% | 7.28% |
| Dec 31, 2020 | 11.38% | 6.62% |
| Dec 31, 2019 | 16.14% | 6.77% |
| Dec 31, 2018 | 13.57% | 5.72% |
| Dec 31, 2017 | 10.25% | 5.00% |
| Dec 31, 2016 | 12.63% | 4.37% |
| Dec 31, 2015 | 12.19% | 4.93% |
| Dec 31, 2014 | 23.01% | 6.03% |
| Dec 31, 2013 | 14.38% | 6.64% |
| Dec 31, 2012 | 13.20% | 7.54% |
| Dec 31, 2011 | 11.95% | 7.54% |
| Dec 31, 2010 | 12.34% | 7.69% |
| Dec 31, 2009 | 14.18% | 8.84% |
| Dec 31, 2008 | 9.21% | 7.51% |
| Dec 31, 2007 | 8.40% | 8.92% |
| Dec 31, 2006 | 10.47% | 7.40% |
| Dec 31, 2005 | 6.45% | 7.94% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Edwards Lifesciences Corp., ROA, long-term trends, comparison to industry (health care)
| Edwards Lifesciences Corp. | Health Care | |
|---|---|---|
| Dec 31, 2021 | 17.68% | 9.46% |
| Dec 31, 2020 | 11.38% | 5.81% |
| Dec 31, 2019 | 16.14% | 8.32% |
| Dec 31, 2018 | 13.57% | 7.90% |
| Dec 31, 2017 | 10.25% | 5.19% |
| Dec 31, 2016 | 12.63% | 7.31% |
| Dec 31, 2015 | 12.19% | 7.71% |
| Dec 31, 2014 | 23.01% | 8.59% |
| Dec 31, 2013 | 14.38% | 8.76% |
| Dec 31, 2012 | 13.20% | 8.09% |
| Dec 31, 2011 | 11.95% | 7.36% |
| Dec 31, 2010 | 12.34% | 7.24% |
| Dec 31, 2009 | 14.18% | 9.73% |
| Dec 31, 2008 | 9.21% | 9.50% |
| Dec 31, 2007 | 8.40% | 8.88% |
| Dec 31, 2006 | 10.47% | 10.52% |
| Dec 31, 2005 | 6.45% | 9.67% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).